Skip to main content
Log in

Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets

  • Rapid Communication
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Fasting serum 1α,25-dihydroxyvitamin D (1,25-(OH)2D) levels were measured in 3 groups of hypophosphatemic vitamin D-resistant rickets (VDRR) patients: those untreated; those treated with vitamin D and phosphate; and those treated with 1,25-(OH)2D3 and phosphate. In the untreated patients, the mean 1,25-(OH)2D level was higher than in our age-matched control group. Except for one at 66 pg/ml, individual values were however within normal limits. Long term vitamin D2 therapy was accompanied by a slight but significant decrease in 1,25-(OH)2D concentrations; nonetheless the levels remained within the normal range. In the third group of patients, the concentration of 1,25-(OH)2D rose to supranormal levels when sampling was done 1–3 hours after administration of the hormone, decreasing rapidly to levels below that of normal subjects when the specimens were collected 12–24 hours later. Our data show that an alteration of the vitamin D activation pathway is unlikely to be part of the pathogenic mechanism underlying the VDRR condition.

Calcitriol (1α,25-(OH)2D3) as RocaltrolR in capsules of 0.25 and 0.50 µg was kindly supplied by Dr. Patrick Le Morvan (Hoffmann-La Roche Ltd, Vaudreuil, Que., Canada).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Glorieux, F.H., Scriver, C.R.: Loss of a PTH sensitive component of phosphate transport in X-linked hypophosphatemia, Science175:997–1000, 1972

    CAS  PubMed  Google Scholar 

  2. Chan, J.C.M., Bartter, F.C.: Hypophosphatemic rickets: Effects of 1α,25-dihydroxyvitamin D on growth and mineral metabolism, Pediatr.64:488–495, 1979

    CAS  Google Scholar 

  3. Scriver, C.R., Reade, T.M., DeLuca, H.F., Hamstra, A.J.: Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease, N. Engl. J. Med.299:976–979, 1978

    Article  CAS  PubMed  Google Scholar 

  4. Haussler, M., Hughes, M., Baylink, D., Littledike, E.T., Cork, D., Pitt, M.: Influence of phosphate depletion on the biosynthesis and circulating level of 1α,25-dihydroxyvitamin D, Adv. Expt. Med. Biol.81:233–250

  5. Arnaud, C.D., Glorieux, F.H., Scriver, C.R.: Serum parathyroid hormone in X-linked hypophosphatemia, Science173:845–847, 1971

    CAS  PubMed  Google Scholar 

  6. Glorieux, F.H., Scriver, C.R., Reade, T.M., Goldman, H., Roseborough, A.: Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia, N. Engl. J. Med.287:481–487, 1972

    Article  CAS  PubMed  Google Scholar 

  7. Haddad, J.G., Chyu, K.J.: Competitive binding radioassay for 25-hydroxycholecalciferol. J. Clin. Endocr.33:992–995, 1971

    CAS  PubMed  Google Scholar 

  8. Eisman, J.H., Hamstra, A.J., Kream, B.E., DelUca, H.F.: A sensitive, precise and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma, Arch. Biochem. Biophys.176:235–243, 1976

    Article  CAS  PubMed  Google Scholar 

  9. Tanaka, Y., DeLuca, H.F.: The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus, Arch. Biochem. Biophys.154:566–574

  10. Eicher, E.M., Southard, J.L., Scriver, C.R., Glorieux, F.H.: Hypophosphatemia: Mouse model for human familial hypophosphatemic vitamin D-resistant rickets, Proc. Natl Acad. Sci. USA73:4667–4671, 1976

    CAS  PubMed  Google Scholar 

  11. Lund, B., Sørensen, O.H., Lund, B., Bishop, J.E., Norman, A.W.: Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and hypocalcemia in man, J. Clin. Endocr. Metab.50:480–484, 1980

    Article  CAS  PubMed  Google Scholar 

  12. Trechsel, U., Eisman, J.A., Fischer, J.A., Bonjour, J.-P., Fleisch, H.: Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D, Am. J. Physiol.2:119E-124E, 1980

    Google Scholar 

  13. Chesney, R.W., Mazess, R.B., Rose, P., Hamstra, A.J., DeLuca, H.F.: Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets, Am. J. Dis. Child.134:140–143

  14. Bell, N.H., Epstein, S., Stern, P.H.: Hypercalcemia during long term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism, N. Engl J. Med.301:1183–1184, 1979

    Article  CAS  PubMed  Google Scholar 

  15. Glorieux, F.H., Bordier, P.J., Marie, P., Travers, P., Delvin, E.E., Pettifor, J.M.: The response of bone to oral phosphate salts, ergocalciferol and/or 1α,25-dihydroxycholecalciferol in familial hypophosphatemia. In A.W. Norman, K. Schaefer, D. von Herrath (eds). Vitamin D: Basic Research and its Clinical Application, pp. 1163–1165. Walter de Gruyter, Berlin, 1979

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delvin, E.E., Glorieux, F.H. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets. Calcif Tissue Int 33, 173–175 (1981). https://doi.org/10.1007/BF02409431

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02409431

Key words

Navigation